ASP1951
ASP1951 (PTZ-522) is a monoclonal antibody that targets GITR and is a GITR agonist. ASP1951 can be used for the research of advanced solid tumours.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
Human
TNFRSF18/GITR/CD357
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
化学情報
-
別名
PTZ-522
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Davar D, et al. Targeting GITR in cancer immunotherapy - there is no perfect knowledge. Oncotarget. 2023;14:614-621. Published 2023 Jun 19. [Content Brief]
[2]. Buzzatti G, et al. New emerging targets in cancer immunotherapy: the role of GITR. ESMO Open. 2020 Aug;4(Suppl 3):e000738. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)